Intended Use

The device is intended to capture, analyze and report symptomatic and asymptomatic cardiac events and continuous electrocardiogram information for long-term monitoring.

Technology

The ZEUS System consists of software modules designed to store and analyze ECG data from compatible single-patient-use cardiac monitoring devices, producing preliminary findings such as beats, ectopic runs, rhythm segments, and heart rate measurements. It uses automated ECG analysis algorithms, with quality control by Certified Cardiographic Technicians, and supports interoperable use with Zio XT and Zio AT Patch devices.

Performance

The device conforms to FDA-recognized consensus standards and guidance documents. Nonclinical testing including software lifecycle, risk management, and electrical safety was conducted. No clinical testing was performed. The modifications from the predicate device did not affect safety or effectiveness, demonstrating substantial equivalence.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    9/1/2020

    8 months
  • 2

    FDA Approval

    5/21/2021

Other devices from iRhythm Technologies, Inc.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.